KOSDAQ · Healthcare · ₩78B
₩5,860+0.34%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 2.1% · as of 26.10.27
Among 21 신약 개발 peers
“신약 개발 진전이 다음 성장 기회를 넓히는 분기예요.”
In the company's words · 2026 2분기 filing